A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men

ResearchWorks/Manakin Repository

Search ResearchWorks


Advanced Search

Browse

My Account

Statistics

Related Information

A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men

Show full item record

Title: A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men
Author: Cui, Yu-Gui; Wang, Xing-Hai; Bremner, William J.; Zhang, Gui-Yuan; Gu, Yi-Qun
Abstract: This is a pilot dose-finding study of spermatogenic suppression using testosterone undecanoate (TU) injections alone in normal Chinese men. Thirty-two healthy men were recruited. Volunteers underwent pretreatment evaluation, then a treatment period in which group I (n = 13) received 500 mg TU, group II (n = 12) received 1000 mg TU, and group III (n = 7) received placebo, respectively, at monthly intervals during the treatment period (or until azoospermia was achieved). Thereafter, they underwent a recovery period until all parameters returned to pretreatment levels. Eleven of 12 volunteers in the 500-mg TU group, and all volunteers in the 1000-mg TU group became azoospermic. Faster suppression of spermatogenesis was achieved in the 1000-mg TU group. Serum testosterone increased significantly in the higher dose group at weeks 8 and 12, but remained within the normal range. Mean serum LH and FSH were profoundly suppressed by both doses to undetectable levels at week 16. TU injections did not cause a significant change in high density lipoprotein cholesterol levels. No serious side-effects were found. We conclude that both dosages of TU can effectively, safely, and reversibly suppress spermatogenesis in normal Chinese men.
URI: http://hdl.handle.net/1773/4404

Files in this item

Files Size Format View
JCEM_1999_Clinical_Trial_Testosterone.pdf 163.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record